| Autor: |
Londoño-Echeverri MA; Escuela de Medicina, Universidad Libre, Cali, Colombia., Vargas-Cely FS; Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia., García-Luna JA; Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia.; Universidad Icesi, Cali, Colombia.; Division of Dermatology, Department of Internal Medicine, School of Medicine, Universidad del Valle, Cali, Colombia., Romero-Rosas NA; Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia.; Universidad Icesi, Cali, Colombia., Muñoz Garcia LE; Universidad Icesi, Cali, Colombia.; Fundación Clínica Valle del Lili, Cali, Colombia., Valderrama N; Division of Dermatology, Department of Internal Medicine, School of Medicine, Universidad del Valle, Cali, Colombia.; Centro de Salud Panamericano, Programa Atención Enfermedad de Hansen, Cali, Colombia., Salazar JC; Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia.; Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut.; Division of Pediatric Infectious Diseases, Connecticut Children's, Hartford, Connecticut.; Department of Immunology, University of Connecticut School of Medicine, Farmington, Connecticut. |
| Abstrakt: |
Competing Interests: Dr García-Luna has received support from Janssen, Carnott, Epidermique, and Cantabria laboratories to attend dermatology meetings in Colombia, outside the scope of this work. Drs Londoño-Echeverri, Vargas-Cely, Romero-Rosas, Muñoz Garcia, Valderrama and Salazar have no conflicts of interest to declare. |
